UBS AM’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
211,344
-80,258
-28% -$503K ﹤0.01% 2278
2026
Q1
$1.76M Buy
291,602
+97,795
+50% +$572K ﹤0.01% 2099
2025
Q4
$1.39M Buy
193,807
+1,147
+0.6% +$8.15K ﹤0.01% 2027
2025
Q3
$1.45M Sell
192,660
-142,732
-43% -$1.04M ﹤0.01% 1873
2025
Q2
$2.09M Buy
335,392
+143,551
+75% +$664K ﹤0.01% 2117
2025
Q1
$599K Buy
191,841
+17,195
+10% +$60.4K ﹤0.01% 2459
2024
Q4
$690K Buy
174,646
+41,437
+31% +$145K ﹤0.01% 2487
2024
Q3
$539K Sell
133,209
-42,465
-24% -$148K ﹤0.01% 2622
2024
Q2
$448K Buy
175,674
+29,013
+20% +$96.1K ﹤0.01% 2650
2024
Q1
$653K Hold
146,661
﹤0.01% 2202
2023
Q4
$692K Buy
146,661
+16,394
+13% +$70.1K ﹤0.01% 2210
2023
Q3
$633K Buy
130,267
+89,367
+219% +$550K ﹤0.01% 2188
2023
Q2
$128K Hold
40,900
﹤0.01% 2619
2023
Q1
$128K Hold
40,900
﹤0.01% 2619
2022
Q4
$106K Hold
40,900
﹤0.01% 2491
2022
Q3
$86.7K Hold
40,900
﹤0.01% 2696
2022
Q2
$109K Hold
40,900
﹤0.01% 2639
2022
Q1
$108K Hold
40,900
﹤0.01% 2734
2021
Q4
$182K Buy
+40,900
New +$230K ﹤0.01% 2773

Other funds holding EVLV

UBS AM's EVLV Position: Q2 2026 in Review

UBS AM reduced its Evolv Technologies (EVLV) stake by 28% in Q2 2026, selling an estimated $503K and leaving 211,344 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

UBS AM first reported a position in EVLV in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.09M in Q2 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • UBS AM held 211,344 shares of Evolv Technologies worth $1.23M as of Q2 2026.
  • UBS AM sold 80,258 Evolv Technologies shares in Q2 2026, an estimated $503K.
  • Evolv Technologies made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2278 holding.
  • UBS AM first reported a position in Evolv Technologies in Q4 2021 and has held it in 19 quarters since.
  • UBS AM's Evolv Technologies position peaked at $2.09M in Q2 2025.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.